|
 |
|
- R. Soltero, N. Ekwirube, F. Opawale, A. Hickey, B. Rehaender, L. Bovet,
"Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods
of treating diseases therewith" United States Patent 6,770,625
- R. Soltero, N. Ekwirube, B. Rehaender, L. Bovet, A. Hickey, "Pharmaceutical
Compositions of Insulin Drug-Oligomer Conjugates and Methods of Treating Diseases
Therewith" United States Patent 6,867,183
- R. Soltero, B. Radhakrishnan, N. Ekwirube, "Methods of Synthesizing Insulin Polypeptide-Oligomer Conjugates, and Proinsulin Polypeptide-Oligomer Conjugates and Methods of Synthesizing Same" United States Patent 6,913,903
- R. Soltero, N. Ekwirube, F. Opawale, B. Rehaender, A. Hickey, "Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith” United States Patent 7,030,082
- R. Soltero, B. Radhakrishnan, N. Ekwirube, “Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same" United States Patent 7,166,571
- R. Soltero, B. Radhakrishnan, N. Ekwirube, B. Rehaender, A. Hickey, L. Bovet, "Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith" United States Patent 7,196,059
- B. Radhakrishnan, R. Soltero, N. Ekwirube, M. Puskas, D. Sangal, "Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same" United States Patent 7,312,192
- B. Radhakrishnan, R. Soltero, N. Ekwirube, "Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same" United States Patent 7,368,260
- R. Soltero, N. Ekwuribe, F. Opawale, B. Rehlander, A. Hickey, L. Bovet, "Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith" United States Patent Application 20030069170
- J. G. Still, R. Soltero, et al., "Methods of Reducing Hypoglycemic Episodes
in the Treatment of Diabetes Mellitus" United States Patent Application
20040038867
- F. Opawale, R. Soltero, "Micro-particle fatty acid salt solid dosage formulations for therapeutic agents" United States Patent Application 20050095216
- R. Soltero, "Method for administering medicaments to subjects with swallowing difficulties and disorders" United States Patent Application 20070196495
- A. McKinney, G. Tollefson, S. Yau, R. Vladyka, R. Soltero, "Sustained Release Formulations of Zonisamide" United States Patent Application 20070148237
- G. Tollefson, A. McKinney. M. Higgin, J. McCall, "Compositions for affecting
weight loss" United States Patent Application 20070117827
- A. McKinney, G. Tollefson, R. Soltero, E. Dunzo, "Sustained Release Formulations of Naltrexone" United States Patent Application 20070281021
- A. McKinney, G. Tollefson, E. Weber, R. Soltero, "Methods for Administering
Weight Loss Medications" United States Patent Application 20080110792
- A. McKinney, G. Tollefson, E. Weber, R. Soltero, "Layered Pharmaceutical Formulations" United States Patent Application 20080113026
- R. Soltero, "System and Method for Developing and Managing a Manufacturing Process" United States Patent Application 20080097804
- R. Soltero, B. Rehlander, "A Method for Stabilizing Acidic and Alkaline
Labile Pharmaceutical Products" PTO Application Number 61059290
- US 4,546,193: Antiarrhythmic cyclooct[b]indoles
- US 4,638,008: Antiarrhythmic agents
- US 4,665,227: N-substituted-4(3)-nitrobenzene sulphonamides
- US 4,698,445: 4-amino benzenesulfonamides
- US 4,721,809: Alkylsulfonamido or perfluoroalkylsulfonamido benzenesulfonamides
- US 4,794,196: N-aminoalkylperfluoroalkanoylaminobenzene-sulfonamide anti-arrhythmic agents
- US 5,002,949: 5-substituted-6-aminopyrimidine derivatives
- US 5,144,072: Anti-arrhythmic agents
- US 6,037,358: Decongestant/antihistaminic compositions
- US 6,287,597: Decongestant/antihistaminic compositions
- US 6,306,904: Antihistaminic/antitussive compositions
- US 6,586,469: Antihistaminic/antitussive compositions
- US 6,630,498: Eprosartan arginyl charge-neutralization-complex and a process for its preparation and formulation
- US D383,533: Pharmaceutical tablet
- US D383,534: Pharmaceutical tablet
Click here for list in PDF format |
|  |